Back to Resource Center

Interim open-label study results suggest higher dapivirine vaginal ring use, lower HIV risk

Interim open-label study results suggest higher dapivirine vaginal ring use, lower HIV risk

March 2018

Click to view Media / News Article

Click for full info +

Full Info:


Resource Type:

Media / News Article

Citation:

IPM. (2018, March 6). Medical Express.   

Health Risks(s):

  • HIV
  • Unintended Pregnancy

Product type(s):

  • Contraceptives
  • IVR
  • MPTs

Topic(s):

  • MPTs
  • Development

      URL of resource:

      https://medicalxpress.com/news/2018-03-interim-open-label-results-higher-dapivirine.html

      Back to Resource Center